Add like
Add dislike
Add to saved papers

Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.

PURPOSE: To analyze the changes in retinal ganglion cells (RGCs) in eyes with nonproliferative macular telangiectasia type 2A (MacTel), by evaluating macular ganglion cell-inner plexiform layer (GCIPL) thickness and macular retinal nerve fiber layer (RNFL) thickness in comparison to age-matched healthy volunteers.

METHODS: We performed a retrospective analysis of 99 eyes (53 subjects) with nonproliferative MacTel who underwent fundus fluorescein angiography and spectral domain optical coherence tomography using Cirrus HD-OCT. We also included 44 eyes of 33 age-matched healthy Indian volunteers as control group. Average, minimum, and sectoral GCIPL and RNFL thicknesses were collected. Comparison of GCIPL and RNFL thicknesses between MacTel and control groups was performed using Wilcoxon rank sum test.

RESULTS: Eighty-eight eyes of 47 MacTel subjects were included after ensuring good quality of the retinal layers' segmentation. Macular GCIPL thickness was constantly and diffusely reduced in MacTel eyes compared with controls (P < 0.0001 for each GCIPL sector). The mean reduction in "average" GCIPL thickness was 11%, and the mean reduction in "minimum" GCIPL thickness was 23%. Similarly, macular RNFL thickness was diffusely reduced in MacTel eyes compared with controls (P < 0.0001 for each RNFL sector), with 13% of mean reduction.

CONCLUSIONS: Our study demonstrated that in eyes with nonproliferative MacTel type 2A there was significant and consistent RGCs degeneration, leading to diffuse thinning of RGCs' dendrites, cell bodies, and axons. These findings are suggestive of neurodegeneration in MacTel type 2A.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app